125 related articles for article (PubMed ID: 14666699)
21. Altered expression of key cell cycle regulators in renal cell carcinoma associated with Xp11.2 translocation.
Barroca H; Castedo S; Vieira J; Teixeira M; Müller-Höcker J
Pathol Res Pract; 2009; 205(7):466-72. PubMed ID: 19246164
[TBL] [Abstract][Full Text] [Related]
22. Cyclin D3 expression in normal, reactive and neoplastic tissues.
Doglioni C; Chiarelli C; Macrí E; Dei Tos AP; Meggiolaro E; Dalla Palma P; Barbareschi M
J Pathol; 1998 Jun; 185(2):159-66. PubMed ID: 9713342
[TBL] [Abstract][Full Text] [Related]
23. Expression profiling of cyclin B1 and D1 in cervical carcinoma.
Zhao M; Kim YT; Yoon BS; Kim SW; Kang MH; Kim SH; Kim JH; Kim JW; Park YW
Exp Oncol; 2006 Mar; 28(1):44-8. PubMed ID: 16614707
[TBL] [Abstract][Full Text] [Related]
24. The effect of cyclin D expression on cell proliferation in human gliomas.
Zhang X; Zhao M; Huang AY; Fei Z; Zhang W; Wang XL
J Clin Neurosci; 2005 Feb; 12(2):166-8. PubMed ID: 15749420
[TBL] [Abstract][Full Text] [Related]
25. A study on the prognostic value of cyclins D1 and E expression levels in resectable gastric cancer and on some correlations between cyclins expression, histoclinical parameters and selected protein products of cell-cycle regulatory genes.
Tenderenda M
J Exp Clin Cancer Res; 2005 Sep; 24(3):405-14. PubMed ID: 16270527
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors: the role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index, and clinicopathologic parameters.
Lopez-Beltran A; Luque RJ; Alvarez-Kindelan J; Quintero A; Merlo F; Requena MJ; Montironi R
Am J Clin Pathol; 2004 Sep; 122(3):444-52. PubMed ID: 15362377
[TBL] [Abstract][Full Text] [Related]
27. Crucial roles of D-type cyclins in the early stage of adipocyte differentiation.
Hishida T; Naito K; Osada S; Nishizuka M; Imagawa M
Biochem Biophys Res Commun; 2008 May; 370(2):289-94. PubMed ID: 18374658
[TBL] [Abstract][Full Text] [Related]
28. Expression of D-type cyclins in normal and neoplastic rat pituitary.
Qian X; Kulig E; Jin L; Lloyd RV
Endocrinology; 1998 Apr; 139(4):2058-67. PubMed ID: 9528994
[TBL] [Abstract][Full Text] [Related]
29. G1-phase regulators, cyclin D1, cyclin D2, and cyclin D3: up-regulation at gastrulation and dynamic expression during neurulation.
Wianny F; Real FX; Mummery CL; Van Rooijen M; Lahti J; Samarut J; Savatier P
Dev Dyn; 1998 May; 212(1):49-62. PubMed ID: 9603423
[TBL] [Abstract][Full Text] [Related]
30. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
[TBL] [Abstract][Full Text] [Related]
31. Cyclin D3 expression in primary Ta/T1 bladder cancer.
Lopez-Beltran A; Requena MJ; Luque RJ; Alvarez-Kindelan J; Quintero A; Blanca AM; Rodriguez ME; Siendones E; Montironi R
J Pathol; 2006 May; 209(1):106-13. PubMed ID: 16482499
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of cyclin D1, D3, and p21 in an infantile renal carcinoma with Xp11.2 TFE3-gene fusion.
Müller-Höcker J; Babaryka G; Schmid I; Jung A
Pathol Res Pract; 2008; 204(8):589-97. PubMed ID: 18358634
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of cyclin D1 and cortactin is primarily independent of gene amplification in salivary gland adenoid cystic carcinoma.
Greer RO; Said S; Shroyer KR; Marileila VG; Weed SA
Oral Oncol; 2007 Sep; 43(8):735-41. PubMed ID: 17113340
[TBL] [Abstract][Full Text] [Related]
34. Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis.
Bartkova J; Lukas J; Strauss M; Bartek J
Oncogene; 1995 Feb; 10(4):775-8. PubMed ID: 7862456
[TBL] [Abstract][Full Text] [Related]
35. D-type cyclins and G1 progression during liver development in the rat.
Boylan JM; Gruppuso PA
Biochem Biophys Res Commun; 2005 May; 330(3):722-30. PubMed ID: 15809057
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical study of cell cycle-associated proteins in adenocarcinoma of the uterine cervix treated with radiotherapy alone: P53 status has a strong impact on prognosis.
Suzuki Y; Nakano T; Kato S; Ohno T; Tsujii H; Oka K
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):231-6. PubMed ID: 15337561
[TBL] [Abstract][Full Text] [Related]
37. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
38. Aberrant expression of cyclin D1 is associated with poor prognosis in early stage cervical cancer of the uterus.
Bae DS; Cho SB; Kim YJ; Whang JD; Song SY; Park CS; Kim DS; Lee JH
Gynecol Oncol; 2001 Jun; 81(3):341-7. PubMed ID: 11371120
[TBL] [Abstract][Full Text] [Related]
39. Gain of 11q/cyclin D1 overexpression is an essential early step in skin cancer development and causes abnormal tissue organization and differentiation.
Burnworth B; Popp S; Stark HJ; Steinkraus V; Bröcker EB; Hartschuh W; Birek C; Boukamp P
Oncogene; 2006 Jul; 25(32):4399-412. PubMed ID: 16547504
[TBL] [Abstract][Full Text] [Related]
40. Bio-pathologic characteristics related to chromosome 11 aneusomy and cyclin D1 gene status in surgically resected stage I and II breast cancer: Identification of an adverse prognostic profile.
Mottolese M; Orlandi G; Sperduti I; Merola R; Buglioni S; Di Benedetto A; Pinnarò P; Perracchio L; Venturo I; Cognetti F; Cianciulli A
Am J Surg Pathol; 2007 Feb; 31(2):247-54. PubMed ID: 17255770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
